Results 1 to 10 of about 17,175,483 (375)
Some of the next articles are maybe not open access.

Immunotherapy of AL Amyloidosis

2004
Jonathan Wall   +2 more
openaire   +2 more sources

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria

Leukemia, 2018
Eli Muchtar   +24 more
semanticscholar   +1 more source

Systemic Equine Al Amyloidosis

2004
Charles L. Murphy   +6 more
openaire   +1 more source

AL Amyloidosis [PDF]

open access: goldOrphanet Journal of Rare Diseases, 2012
Definition of the disease AL amyloidosis results from extra-cellular deposition of fibril-forming monoclonal immunoglobulin (Ig) light chains (LC) (most commonly of lambda isotype) usually secreted by a small plasma cell clone.
Desport Estelle   +13 more
doaj   +10 more sources

Misdiagnosis of hereditary amyloidosis as AL (Primary) amyloidosis [PDF]

open access: bronzeNew England Journal of Medicine, 2002
Background: Hereditary, autosomal dominant amyloidosis, caused by mutations in the genes encoding transthyretin, fibrinogen A -chain, lysozyme, or apolipoprotein A-I, is thought to be extremely rare and is not routinely included in the differential ...
Booth, D.R.   +7 more
core   +8 more sources

Management of AL amyloidosis in 2020. [PDF]

open access: yesHematology, 2020
In amyloid light chain (AL) amyloidosis, a small B-cell clone, most commonly a plasma cell clone, produces monoclonal light chains that exert organ toxicity and deposit in tissue in the form of amyloid fibrils.
G. Palladini, P. Milani, G. Merlini
semanticscholar   +9 more sources

Biomarkers in AL Amyloidosis [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Systemic AL amyloidosis is a rare complex hematological disorder caused by clonal plasma cells which produce amyloidogenic immunoglobulins. Outcome and prognosis is the combinatory result of the extent and pattern of organ involvement secondary to ...
D. Fotiou   +2 more
semanticscholar   +4 more sources

Epidemiology of AL amyloidosis: a real-world study using US claims data

open access: yesBlood Advances, 2018
: Amyloid light-chain (AL) amyloidosis is a rare disease caused by extracellular deposition of misfolded immunoglobulin light chains. This study aimed to provide an up-to-date estimate of prevalence and incidence of AL amyloidosis in the United States ...
Tiffany P. Quock   +4 more
doaj   +2 more sources

A RARE PRESENTATION OF SYSTEMIC AL AMYLOIDOSIS; PULMONARY AL AMYLOIDOSIS

open access: yesHematology, Transfusion and Cell Therapy, 2022
Objective: Involvement of the lung is common in systemic AL amyloidosis in post-mortem series. However, the diagnosis is challenging. Histology is the gold standard but may result in bleeding. Consequently, diagnosis during life is rare.
Simge ERDEM   +4 more
doaj   +2 more sources

Chronic Viral Infections and Al Amyloidosis: An Uncommon Association [PDF]

open access: yesClinical Case Reports
AL‐amyloidosis is caused by deposition of pathological insoluble proteins in organs and tissues. HIV infection is a multi‐system disorder causing chronic inflammation.
Alberto Palladini   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy